Neuprotect's Series A Round

Neuprotect raised a round of funding on February 23, 2004. Investors include Starfish Ventures.

Neuprotect is a life sciences company developing lead cardioprotectant and neuroprotectant small molecules to reduce tissue damage following a heart attack or stroke. Its lead compound is presently in…

Articles about Neuprotect's Series A Round: